• Latest Posts

PACT Pharma reports data from CRISPR cancer study

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

Interview 17 Oct 2022

CRISPR gene editing: a key tool for counteracting climate change

The challenges of translating CRISPR to the clinic

More News! 29 Sep 2022

Removing binding sites for an oncogene can slow cancer cell growth, researchers say


Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies

Lesaffre acquires genome editing company Recombia Biosciences

Gene therapies for lung cancer identified by international team of scientists

Interview 10 Aug 2022

How the UK precision breeding bill could unshackle gene editing

Epigenic Therapeutics raises $20M for gene editing technology

Poseida Therapeutics and Roche to focus on therapies for hematologic malignancies